Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.94
+0.29 (1.58%)
Sep 23, 2026, 10:02 AM EDT - Market open
Legend Biotech Employees
Legend Biotech had 2,965 employees as of December 31, 2025. The number of employees increased by 356 or 13.65% compared to the previous year.
Employees
2,965
Change (1Y)
356
Growth (1Y)
13.65%
Revenue / Employee
$428,803
Profits / Employee
-$30,860
Market Cap
3.67B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,965 | 356 | 13.65% |
| Dec 31, 2024 | 2,609 | 783 | 42.88% |
| Dec 31, 2023 | 1,826 | 436 | 31.37% |
| Dec 31, 2022 | 1,390 | 319 | 29.79% |
| Dec 31, 2021 | 1,071 | 189 | 21.43% |
| Dec 31, 2020 | 882 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 289 |
| uniQure | 221 |
| IDEAYA Biosciences | 145 |
LEGN News
- 8 days ago - Legend Biotech taps Novartis veteran Zhang as CEO - Reuters
- 8 days ago - Legend Biotech appoints Ingrid Zhang as CEO - TheFly
- 8 days ago - Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer - GlobeNewsWire
- 8 days ago - Legend Biotech is tapping a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in July - WSJ
- 12 days ago - Legend Biotech price target lowered to $74 from $78 at Barclays - TheFly
- 13 days ago - Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting - GlobeNewsWire
- 22 days ago - Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Legend Biotech price target lowered to $24 from $29 at TD Cowen - TheFly